Results 311 to 320 of about 1,782,711 (374)

Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease.

Current Medicinal Chemistry, 2012
There is evidence that Trigonella foenum-graecum L. (fenugreek), a traditional Chinese herb, and its components are beneficial in the prevention and treatment of diabetes and central nervous system disease. The pharmacological activities of trigonelline,
J. Zhou, L. Chan, S. Zhou
semanticscholar   +1 more source

Amyloid in central nervous system disease

Clinical Neurology and Neurosurgery, 1990
A review is presented of diseases of the central nervous system associated with amyloid deposition. The name amyloid is given to substances with particular physical characteristics which are independent of the chemical constitution of the proteins in the substance.
J. Haan, R.A.C. Roos
openaire   +3 more sources

Central nervous system Lyme disease

Seminars in Pediatric Infectious Diseases, 2003
Lyme disease is a disease caused by the spirochete, Borrelia burgdorferi. It is transmitted to humans via a bite from an infected tick. It has several classic stages or categories of illness, including early localized disease, early disseminated disease, and late disease.
Lucy Pontrelli, Sharon Nachman
openaire   +3 more sources

Circadian variation of the plasma 17-hydroxycorticosteroids in central nervous system disease.

Journal of Clinical Endocrinology and Metabolism, 1966
The pattern of the circadian variation of the plasma 17-OHCS was studied in 48 patients with focal disease of the central nervous system unassociated with disturbance of consciousness.
D. Krieger, H. P. Krieger
semanticscholar   +1 more source

Ergothioneine and central nervous system diseases

Neurochemical Research, 2022
Ergothioneine (ERGO) is a thiol contained in the food that exhibits an excellent antioxidant effect similar to that of glutathione. Although mammals lack a biosynthetic pathway for ERGO, the carnitine/organic cation transporter OCTN1/SLC22A4, which transports ERGO in vivo, is expressed throughout the body, and ERGO is distributed to various organs ...
Noritaka Nakamichi, Sota Tsuzuku, Fumiya Shibagaki   +2 more
openaire   +2 more sources

Batokine in Central Nervous System Diseases

Molecular Neurobiology, 2023
Brown adipose tissue (BAT) is a special type of fat tissue in mammals and is also a key endocrine organ in the human body. Batokine, the endocrine effector of BAT, plays a neuroprotective role and improves the prognosis by exerting anti-apoptotic and anti-inflammatory effects, as well as by improving vascular endothelial function and other mechanisms ...
Ming Shen, Min Zhang, Niping Mao, Zhenlang Lin   +3 more
openaire   +2 more sources

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis.

Annals of Internal Medicine, 1986
Central nervous system involvement has occurred in approximately 20% of patients with primary Sjögren's syndrome evaluated at our institution. Characteristically, the neurologic dysfunction is multifocal, involving both the brain and spinal cord, and is ...
E. Alexander, K. Malinow, J. E. Lejewski, M. Jerdan, T. Provost, G. E. Alexander   +5 more
semanticscholar   +1 more source

Whipple's disease of the central nervous system

Acta Neuropathologica, 1976
Whipple's disease presenting as a neurological disease without gastrointestinal symptoms is an unusual occurrence. A 40 year old man suffered hypersomnia, memory loss and progressive ophthalmoplegia for 6 months prior to death. The nature of this disease was not established during life.
Shirley W. Silbert, Shirley W. Silbert, Eugenia Parker, Eugenia Parker, Simon Horenstein, Simon Horenstein   +5 more
openaire   +3 more sources

Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MR imaging, and pathologic studies.

Radiology, 1986
A prospective study compared the abilities of high-resolution computed tomography (HRCT) and magnetic resonance (MR) imaging in detection and evaluation of central nervous system disease in neurologically symptomatic patients with acquired ...
M. Post, J. Sheldon, G. Hensley, K. Soila, J. Tobias, J. Chan, R. Quencer, L. Moskowitz   +7 more
semanticscholar   +1 more source

Granulomatous Diseases of the Central Nervous System

Current Neurology and Neuroscience Reports, 2022
To discuss the pathophysiology, key clinical features, necessary diagnostic evaluation, and current treatment regimens for granulomatous diseases of the central nervous system.The diagnosis and management of granulomatous disease of the central nervous system has been revolutionized by advances in diagnostic imaging.
Braden, Dasovic, , Ewa Borys, Michael J, Schneck   +2 more
openaire   +2 more sources